MWR
GILD icon

McAdams Wright Ragen’s Gilead Sciences GILD Stock Holding History

McAdams Wright Ragen’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3.01M Buy
28,296
+1,473
+5% +$144K 0.17% 119
2014
Q2 		$2.22M Buy
26,823
+21,911
+446% +$1.71M 0.12% 139
2014
Q1 		$348K Buy
4,912
+850
+21% +$66.7K 0.02% 282
2013
Q4 		$305K Buy
+4,062
New +$283K 0.02% 286

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

McAdams Wright Ragen's GILD Position: Q3 2014 in Review

McAdams Wright Ragen increased its Gilead Sciences (GILD) stake by 5.5% in Q3 2014, buying an estimated $144K and bringing the position to 28,296 shares worth $3.01M. The position accounts for 0.17% of the portfolio, ranked #119.

McAdams Wright Ragen first reported a position in GILD in Q4 2013 and has held it in 4 quarters since. 1,326 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • McAdams Wright Ragen held 28,296 shares of Gilead Sciences worth $3.01M as of Q3 2014.
  • McAdams Wright Ragen bought 1,473 Gilead Sciences shares in Q3 2014, an estimated $144K.
  • Gilead Sciences made up 0.17% of McAdams Wright Ragen's portfolio in Q3 2014, its #119 holding.
  • McAdams Wright Ragen first reported a position in Gilead Sciences in Q4 2013 and has held it in 4 quarters since.
  • 1,326 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.